Member AUM
$75 trillion
glyph/search
Logout
Login
Sign Up
glyph/search
Tools
Engagements
Policy
Investor Statements
Resource Library
Themes
News & Events
About
Related News
glyph/search
Filter by:
Year
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Theme
Alternative Proteins
Antibiotics & Health
Biodiversity
Climate
Multiple ESG Themes
Social Risk
Project
Alternative Proteins Framework
Alternative Proteins Regulations
Alternative Proteins Venture Investments
Amazon Soy Moratorium
Animal Pharmaceuticals Engagement
Antibiotics Statement
Antibiotics Stewardship Engagement
COP26 Investor Statement
Cerrado Manifesto
Coller FAIRR Climate Risk Tool
Coller FAIRR Protein Producer Index
Coller FAIRR Protein Producer Index - Supply Chain Analysis
Company Focus
EU CAP Reforms
EU Taxonomy
G20 Agricultural Subsidies
G7 Finance AMR
General FAIRR Assets
Global Roadmap to 2050
Investor Action on AMR Public Investor Statement
Meat Sourcing Engagement
Policy Consultations
Policy White Paper
Protein Diversification Engagement
Regenerative Agriculture
Research
Restaurant Antibiotics Engagement
Seafood Traceability Engagement
Sustainable Aquaculture Engagement
Sustainable Proteins Engagement
Waste & Pollution Engagement
Working Conditions Engagement
Video
Multiple ESG Topics
FAIRR's Second Quarter Update 2024
30 October 2024
Log in to be able to follow
Insight
Antibiotics & Health
AMR
Investor Stewardship: Supporting Global Action on Antimicrobial Resistance in 2024
17 September 2024
Log in to be able to follow
Press Release
AMR
Antibiotics & Health
US $13 Trillion Investors Call on Global Leaders To Tackle Antimicrobial Resistance Crisis
3 September 2024
Log in to be able to follow
Video
Multiple ESG Topics
FAIRR's First Quarter Updates 2024
10 July 2024
Log in to be able to follow
Insight
Biodiversity
Antibiotics & Health
Pesticide Use by Protein Producing Companies and the Global Regulatory Divide
25 June 2024
Log in to be able to follow
Insight
Animal Welfare
Antibiotics & Health
Global Readiness, Local Outbreaks
31 May 2024
Log in to be able to follow
Press Release
AMR
Antibiotics & Health
New Investor Statement Targets Global Action on Antimicrobial Resistance
14 May 2024
Log in to be able to follow
Event
AMR
Antibiotics & Health
Fireside Chat | Institutional Investors: Allies in the Fight Against AMR
15 April 2024
Log in to be able to follow
Event
AMR
Antibiotics & Health
AMR: Investors’ Role in Curbing the Silent Pandemic
8 August 2023
Log in to be able to follow
Weekly Digest
Multiple ESG Topics
The Protein Pulse, 7 - 13 July
14 July 2023
Log in to be able to follow
Press Release
AMR
Antibiotics & Health
$15.2T Investors Ask Global Fast Food Companies to Demonstrate Responsible Antibiotic Use in Meat Supply Chain
12 July 2023
Log in to be able to follow
Press Release
AMR
Antibiotics & Health
FAIRR Initiative Comments on Antibiotic-resistant Salmonella
21 June 2023
Log in to be able to follow
Press Release
AMR
Antibiotics & Health
New FAIRR Engagement to Understand if Fast Food Chains Are Adequately Addressing AMR Threat
22 May 2023
Log in to be able to follow
Event
Multiple ESG Topics
AMR in Animal Agriculture: A Call to Action for Animal Pharmaceutical Companies
18 April 2023
Log in to be able to follow
Weekly Digest
Multiple ESG Topics
The Protein Pulse, 24 February – 2 March
3 March 2023
Log in to be able to follow
Weekly Digest
Multiple ESG Topics
The Protein Pulse, 10 – 16 February
17 February 2023
Log in to be able to follow
Event
Multiple ESG Topics
Investing Towards Food Security
8 February 2023
Log in to be able to follow
Weekly Digest
Multiple ESG Topics
The Protein Pulse, 27 January – 2 February
3 February 2023
Log in to be able to follow
